Vitamin A supplementation during pregnancy for reducing the risk of mother-to-child transmission of HIV
Guideline
Overview
This guideline provides global, evidence-informed recommendations on the use of vitamin A supplements for reducing the risk of mother-to-child transmission of the human immunodeficiency virus (HIV) in populations where vitamin A deficiency may be a public health concern.
The guideline will help Member States and their partners in their efforts to make informed decisions on the appropriate nutrition actions to achieve the Millennium Development Goals, in particular, reduction in child mortality (MDG 4), improvement in maternal health (MDG 5) and combating HIV/acquired immune deficiency syndrome (AIDS), malaria and other diseases (MDG 6). The guideline is intended for a wide audience including policy-makers, their expert advisers, and technical and programme staff in organizations involved in the design, implementation and scaling-up of nutrition actions for public health.
Downloads
- Farsi
pdf, 1.78Mb - Portuguese
pdf, 630.38kb
Evidence
- Wiysonge CS, Ndze VN, Kongnyuy EJ, Shey MS.
Vitamin A supplements for reducing mother‐to‐child HIV transmission. Cochrane Database of Systematic Reviews 2017, Issue 9. Art. No.: CD003648. DOI: 10.1002/14651858.CD003648.pub4. - Horvath T, Madi BC, Iuppa IM, Kennedy GE, Rutherford GW, Read JS.
Interventions for preventing late postnatal mother-to-child transmission of HIV. Cochrane Database of Systematic Reviews, 2009, (1): CD006734.